Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 17, 2013
Grant Date -
Mar 1, 2012
app pub date -
Jun 1, 2011
filing date -
Dec 1, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Nanoemulsified topical formulation comprising curcumin, tetrahydroxycurcumin (BDMC) and curcuminoid either alone or in combinations in an amount of 0.001% to 50% together with one or more pharmaceutically, nutraceutically or dietically acceptable excipient(s) or inactive ingredients, useful for the treatment of inflammation, various skin and oral disorders, mucosal disorders and other diseases associated or related thereof.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully